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ABSTRACT
Objective: The present study is to formulate and optimization of surfactant, cosurfactant, and oil of ketoconazole nanoemulsion.
Methods: Ketoconazole was dissolved in surfactant, cosurfactant, and oil until saturated, clear solution extracted with methanol, its absorbance was 
measured using a UV spectrophotometer at 243 nm. Comparisons of surfactants, cosurfactants, and oils are variously varied. Formulation method was 
performed using spontaneous nanoemulsion method.
Results: Surfactants, cosurfactants, and oils used for the nanoemulsion formula are tween 80, ethanol, and isopropyl myristate (IPM). Formulation of 
ketoconazole nanoemulsion with comparison of tween 80 concentration with ethanol (smix) 4:1 and smix with oil 9:1 was found that the formulae F1, 
F2, F3, F4, F5, F6, and F7 are unstable and the formulae F8, F9, F10, F11, and F12 are stable at the period of manufacture. The best physical stability 
tests from F8, F9, F10, F11, and F12 are F10.
Conclusions: Optimization of ketoconazole nanoemulsion formula was obtained at Tween 80, 36% concentration, 9% ethanol, and IPM 5%.
Keywords: Optimization, Ketoconazole, Nanoemulsion.
INTRODUCTION
Topical drug delivery methods have advantages over other delivery 
methods, one of which is to avoid the metabolism of the first pass effect 
on the liver [1]. Physical-chemical characteristic of drugs and excipients 
is taken into consideration in designing formulas to produce a product 
that is stable, efficacious, attractive, easy to formulate, and safe. These 
characteristics affect several factors: Particle size distribution, drug 
dissolution rate, bioavailability, uniformity of content, taste, texture, 
color, and stability. The particle size and solubility of the drug have 
an effect on the formulation because the drugs entering the blood 
circulation must be in solution form to produce the desired effect.
Ketoconazole is included in Class II of Biopharmaceutical Classification 
System means, including a class of low solubility and high permeability, 
the increased solubility of this drug is of concern to pharmaceutical 
researchers [2]. The absorption of ketoconazole orally is not maximal 
due to the solubility and the side effects it causes to overcome the 
deficiencies of this conventional system a new drug delivery system is 
required. Topical ketoconazole available on the market today, such as 
cream has side effects such as rash, itching, irritation, pain, and redness, 
therefore, to overcome this problem, requires a new drug delivery 
system such as nanoemulsion. Nanoemulsion has been widely used as 
a vehicle in topical medicine and is an alternative to insoluble, topical, 
or oral drugs.
Nanoemulsions are thermodynamically stable dispersions of two 
immiscible liquids (oil and water) which are stabilized using a 
surfactant and cosurfactant molecule. They may be either transparent 
or translucent and have a droplet size of 5–200 nm [3]. They are 
well tolerated orally on the skin and mucous membrane when used 
to deliver topically active drugs. Nowadays, increasing drug loading, 
enhancing drug solubility, and bioavailability are the most important 
advantages encouraging the usage of nanoemulsion as drug delivery 
carriers. A topical nanoemulsion is a form of delivery for a drug 
that is difficult to dissolve and has side effects when administered 
orally by increasing the penetration of the drug through the skin 
[4]. Nanoemulsions comprise safe surfactants with or without other 
emulsifiers to improve stability, oil (natural/synthetic/semi-synthetic) 
and cosurfactant [4].
The method of nanoemulsion formulation is divided into two methods 
that use high energy and low energy. High energy formulations 
require tools such as high-pressure homogenizers, microfluidizers, 
and sonicators, low energy formulation methods dependent on the 
solubility of the active substance so that it is more efficient to make a 
small droplet nanoemulsion. Nanoemulsions produced with low energy 
methods depend on the spontaneous formation of emulsions based on 
the phase behavior of certain surfactant, oil, and water systems. There 
is interest in using lower energy techniques in the emulsion formation 
process due to the economic benefits and increasing amounts of 
research have been conducted to investigate the utility of different low-
energy approaches. Self-emulsifying systems offer a strategy for dealing 
with the low bioavailability of compounds (drugs and oils) that are not 
easily dissolved in water [5].
A low energy emulsification or spontaneous emulsification method 
used by the laboratory scale to achieve small droplet size using simple 
instruments [6]. The advantage of the low energy method is that it 
can use simple equipment such as a magnetic stirrer, which includes 
low energy manufacturing methods are phase inversion temperature 
and phase inverse composition (PIC). The nanoemulsion method of 




Ketoconazole (PT. Kimia Farma Plant Tj Morawa Medan), coconut oil, 
castor oil, sesame oil, propylene glycol (PT Brataco, Indonesia) Tween 
20, Tween 80, polyethylene glycol 400, isopropyl myristate (IPM), 
methanol, ethanol, butyl hydroxy toluene (Merck, Germany).
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Screening of ketoconazole solubility in oil surfactant and cosurfactant
An excess amount of drug (±250 mg) in 5 ml of selected oils, surfactants, 
and cosurfactants (coconut oil, castor oil, sesame oil, polyethylene 
glycol 400, Tween 80, Tween 20, propylenglycol, glycerin, and ethanol) 
fixed by the vortex mixer. The mixture is stirred in the shaker for 
24 h. The ketoconazole sample was taken from the saturated oil phase 
and centrifuged at 3000 rpm 15 min. The solubility of drugs in oils, 
surfactants, and cosurfactants is determined by the supernatant layer 
of the centrifuged sample. Then 1 ml of supernatant layer was diluted 
up to 10 ml using methanol. The concentration of ketoconazole was 
then measured by a UV spectrophotometer at 243 nm [9-11].
Optimization of oils, surfactants, and cosurfactants
Optimization of surfactant concentrations, cosurfactant and oil were 
using different ratio The ratio of surfactant mixture to cosurfactant 
(smix) varies from 4:1, 3:1, 2:1, and 1:1. The ratio of oil and smix 
concentration is 1:9, 2: 8, 3:1, 4:6, 5:5, 6:4, 7:3, 8:2, and 9:1. Aquades 
is added with titration and stirred using a magnetic stirrer until it 
becomes translucent and no phase separation [10].
Evaluation of nanoemulsion
Organoleptic
Observations on any changes of color, odor, clarity, and phase separation 
were made.
The pH value
An important parameter of nanoemulsion evaluation is pH 
determination. The excipients used in the formulation decide the pH 
of the final preparation, and hence, the route of administration. The pH 
of the formulation was measured using a digital pH meter. The results 
were taken in triplicate to reduce the error [12].
Viscosity
The viscosity of nanoemulsion was measured using the Brookfield 
viscometer at room temperature (23°C±2°C). Viscosity measurements 
used two spindles speed and experiments were conducted 3 times [10].
Nanoemulsion type
Determination of nanoemulsion type was done by dissolving the 
emulsion in methylene blue. If the preparation is a type of oil in water, 
then the color will dissolve and diffuse. If the preparation is a type of 
water in oil, the methylene blue globules are located on the surface.
Particle size and globule size distribution
Particle size and globule size distribution were measured using particle 
size analyzer (PSA) SZ-100 [13].
Physical stability test
These tests included the cycling test, 8-week storage at temperatures of 
4°C ± 2°C, 25°C ± 2°C, and 40°C ± 2°C, and the centrifugation test speed 
of 3800 rpm for 5 h [13].
RESULT AND DISCUSSION
Solubility study
The solubility of ketoconazole in oil, surfactant, and cosurfactant is 
shown in Table 1. From Table 1 result, the best solubility of ketoconazole 
is Tween 80 (surfactant), ethanol (cosurfactant), and IPM (oil).
Optimization of oils, surfactants, and cosurfactants
Mixing is done carefully and observed so that the unstable preparations 
which have cloudy and phase separation are not selected for further 
experiments. The aim of the optimization from each stage in the 
formulation is to get the best formula. The results from the observations 
of mixtures of tween 80 and ethanol (smix) with IPM are shown in 
Table 2.
The best comparison of tween 80 and ethanol (smix) is 4:1 which will 
be taken to make the nanoemulsion formula. The ratio of smix and oil 
is 9:1 and the ketoconazole nanoemulsion is made as shown in Table 3.
The excipient concentration of the F1, F2, F3, F4, and F5 nanoemulsions 
formula has not been able to stabilize the preparation because after 
stirring it is still cloudy and precipitating. Formulae F6 and F7 were 
initially stable and clear, but after waiting for some time, the formula 
became slightly cloudy and precipitated because the excipient 
concentration has not been able to stabilize nanoemulsion. Formulae 
F8 to F12 are stable and clear can be continued for further testing, while 
for formulae F1 to F7 cannot be continued because they were not stable.
Evaluation of nanoemulsion
The results of the evaluation of nanoemulsion in the 1st week are shown 
in Table 4.
Organoleptic
Formulae F8, F9, F10, F11, and F12 have a soft yellow color, slightly 
viscous, translucent, and homogeneous and have no phase separation. 
This indicates that the concentration of oil (IPM), surfactant (tween 80), 
and cosurfactant (ethanol 96%) used is appropriate. When applied to 
the skin, the formula easily dissolves and leaves a slightly sticky nuance. 
This is because the concentration of tween 80 is high.
pH
The desired pH of the formulation is in the pH range of the skin (4.5–
6.5). PH should not be too acid because it can irritate the skin should 
not be too alkaline because it can cause scaly skin [14]. All the formulas 
that are made have a pH that is still within the pH range of the skin.











Table 2: Observation of mixed comparisons of tween 80 and 
ethanol (smix) with IPM
Smix: 
oil
Observations of mixtures of tween 80 and 
ethanol (smix)
1:1 2:1 3:1 4:1
1:9 √√√ √√√ √√√ √√√
2:8 √√√ √√√ √√√ √√√
3:7 √√√ √√√ √√√ √√√
4:6 √√√ √√√ √√√ √√√
5:5 √√√ √√√ √√√ √√√
6:4 √√√ √√√ √√√ √√
7:3 √√√ √√√ √√√ √√
8:2 √√√ √√√ √√ √√
9:1 √√√ √√√ √√ √
√√√: Cloudy, √√: Slightly cloudy, √: Translucent, IPM: Isopropyl myristate
Formulation of nanoemulsion
Nanoemulsion  formulation  was  performed  using 
spontaneous  emulsification  method.  Ketoconazole  is  added to  the 
oil  phase  which  has  added  butylated  hydroxytoluene  to 
homogeneous, add a smix solution which is a mixture of surfactant 
and  cosurfactant,  then  stirred  with  the  magnetic  stirrer  until 
homogeneous.  Aquades  is  added  by  means  of  titration,  stirred 
continuously  until  nanoemulsion  is  formed  which  is  marked  by  the 
formation of a translucent solution [10].
145
Asian J Pharm Clin Res, Vol 11, Issue 5, 2018, 143-146
 Ernoviya et al. 
Viscosity
Measurement of viscosity was performed using Brookfield viscometer. 
Five formulas of this emulsion showed  various viscosity. Based on the 
optimal results in the increase of oil concentration in the formula, the 
concentration of tween 80 as surfactant will also increase so that it will 
affect its viscosity; in Fig. 1, it is shown that the high concentration of tween 
80 will increase its viscosity. The higher concentration of tween 80, it can 
decrease the globule size. Diminished globule size increases the number 
of particles, which is associated with the system’s attempt to maintain a 
stable mass. Increasing the number of small globules will increase the 
interaction between globules, thus increasing the viscosity [15,16].
Nanoemulsion type
All formulas contain nanoemulsion type oil in water (o/w). This 
is because most of the components present in the formula are 
hydrophilic or polar so that while there is a hydrophobic component, 
the nanoemulsion type remains oil in water (o/w). The results are in 
accordance with the desired because the type nanoemulsion o/w easily 
removed from the skin.
Particle size and globule size distribution
Measurements were made using PSA in the 1st week. The particle 
measurement results show that each formula has a variable size, this is 
due to the difficulty of homogenizing two different systems, in addition 
to several other factors such as duration or speed of stirring also causes 
the formula is not homogeneous. The particle size from the 1st week of 
the eighth increases, as most of the tween 80 undergoes hydrolysis, thus 
reducing the effectiveness of the globule nanoemulsion interface film 
layer [17]. Temperature modification during storage can cause a decrease 
in the effectiveness of the surfactant so that oil droplets tend to close 
together and eventually the droplets produce larger droplets. Globule 
size distribution is an important characteristic of the nanoemulsion 
system, as it may affect drug release and stability of the preparation [18].
The polydispersity index (PDI) is an indicator of the size distribution 
of particle in the emulsion, PDI value close to zero denotes the 
monodispersion system and PDI value close to 1.0 suggesting that the 
emulsion has a very broad size distribution. Therefore, PDI values lower 
than 0.2 indicate homogenous populations, while a 0.3 value represents 
heterogeneity. The desirable characteristics of the formulation are the 
high stability of two immiscible components to stay mixed as one phase 
emulsion. The acceptable PDI value should be <0.7 depending on the 
sample type [19].
The results of this study indicate that the PDI values for the F8 and F9 
formulas are >0.7 which means that the two formulas have a broad 
particle size distribution (polydispersion) and include unstable formula. 
The PDI value of the formulae F10 to F12 is below 0.7, so it belongs to 
the polydispersion category and is still included in the stable formula 
category. The measurement result of particle size and globule size 
distribution of nanoemulsion formula using PSA is shown in Table 5.
Physical stability test
Storage at a temperature of 4° ± 2°C
All formulas are stable until the storage of the 5th week, but in the 
6th week, the formulae F8 and F9 become unstable because at the 
bottom of the glass there are fine particles. This is due to the decreasing 
effectiveness of the surfactant so that the oil droplets tend to close 
together and eventually the united droplets produce larger droplets 
that settle on the bottom of the glass.
Storage at a temperature 25° ± 2°C
All formulas are stable until the storage of the 5th week, but in the 
6th week, the formulae F8 and F9 become unstable because at the bottom 
of the glass there are fine particles. This is because the surfactant has 
not been effective for dissolving ketoconazole and its effectiveness in 
the formula is also decreased so that the ketoconazole molecules tend 
to unite and that settle on the bottom of the glass [15].
Storage at a temperature 40° ± 2°C
All formulas were stable in storage until week 7, in the 8th week with 
the formulae F11 and F12 unstable because the color changed to weak 
orange and the pH decreased. At high concentrations of tween 80 and 
increased temperatures, degradation rate increased due to the tween 
80 autoxidation reaction [17,20].
Cycling test
All formulas are stable during storage.
Centrifugation test (mechanical test)
All formulas are stable and there is no phase separation, which means 
that all formulas are stable against the gravitational force experienced 
for 1 year.
Table 3: Optimization of drug loaded nanoemulsion
Composition (%) Formula
F1 F2 F3 F4 F5 F6 F7 F8 F9 F10 F11 F12
Ketoconazole 2 2 2 2 2 2 2 2 2 2 2 2
IPM 0.5 1.0 1.5 2.0 2.5 3.0 3.5 4.0 4.5 5.0 5.5 6.0
Ethanol 0.9 1.8 2.7 3.6 4.5 5.4 6.3 7.2 8.1 9.0 9.9 10.8
Tween 80 3.6 7.2 10.8 14.4 18.0 21.6 25.2 28.8 32.4 36.0 39.6 43.2
BHT 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1
Aquades 92.9 87.9 82.9 77.9 72.9 67.9 62.9 57.9 52.9 47.9 42.9 37.9
IPM: Isopropyl myristate, BHT: Butylated hydroxytoluene
Table 4: Evaluation of nanoemulsion in the 1st week
Formula Color Odor Clarity pH Viscosity
F8 Soft yellow Specific Translucent 6.10 516.67
F9 Soft yellow Specific Translucent 6.03 533.33
F10 Soft yellow Specific Translucent 6.10 550.00
F11 Soft yellow Specific Translucent 5.97 558.33
F12 Soft yellow Specific Translucent 5.97 583.33
Fig. 1: Graph of viscosity measurement of formula
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CONCLUSIONS
Optimization of surfactants, cosurfactants, and oils to form a 
stable ketoconazole nanoemulsion formulation by spontaneous 
emulsification method can be at surfactant concentrations (tween 80) 
36%, cosurfactant (ethanol) 9%, and oil 5% (IPM).
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